Clinical Trials Directory

Trials / Unknown

UnknownNCT05823935

Laparoscopic Versus Vaginal Cuff Closure During LH in Benign Gynecological Lesions

Laparoscopic Versus Vaginal Cuff Closure During Laparoscopic Hysterectomy in Benign Gynecological Lesions

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
Female
Age
30 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To compare vaginal cuff closure via Bakay purse string with vaginal cuff closure via vaginal route with continuous locked suturing after total laparoscopic hysterectomy for benign lesions.

Detailed description

The objective of the present study is to compare 2 different methods for vaginal cuff closure after total laparoscopic hysterectomy for benign lesions regarding operative time, vaginal length, vaginal cuff dehiscene, hematoma formation. The first method is the Bakay purse string and the second is the closure of the vault via vaginal route with continuous locked suturing.

Conditions

Interventions

TypeNameDescription
PROCEDUREBakay purse stringAfter developing the bladder flap, Vicryl polyglactin 910 sutures (Ethicon, Inc, Somerville, NJ) will be placed on the line between the cervicovaginal junction and the bladder starting at either 4 to 3 o'clock or 8 to 9 o'clock, as anchor sutures. Paying attention not to get closer than 1 cm to the bladder, the first suture will be passed from 4 o'clock to 3 o'clock and continued circumferentially in a full-thickness purse string fashion through 3, 1, 10, 8, 7, 5 o'clock completing a circle while including both uterosacral ligaments.
PROCEDURECuff closure via vaginal route groupAfter the uterus will be removed via vaginal route, vaginal cuff ends will be grasped via vaginal approach and sutured continuous locked sutures using Vicryl polyglactin 910 sutures in one layer.

Timeline

Start date
2022-11-05
Primary completion
2023-11-01
Completion
2023-11-01
First posted
2023-04-21
Last updated
2023-04-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05823935. Inclusion in this directory is not an endorsement.